Search research articles
Contact Us
Filters
Showing results (11-20 of 99) with videos related to
Page
of 10
Sort By:
BMC Infectious Diseases
|
March 1, 2017
The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment
Ivo K Joore, Suzanne E Geerlings, Kees Brinkman, et al.
Chronic Respiratory Disease
|
February 9, 2024
Two-year diffusion capacity trajectory in COVID-19 pneumonia survivors
Marlise P de Roos, Rick M Heijnen, Nynke G Dijkstra, et al.
International Journal of Clinical Pharmacy
|
March 7, 2020
Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Femke Besemer, Cornelis Kramers, Kees Brinkman, et al.
The Lancet. Infectious Diseases
|
June 14, 2015
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Mikaela Smit, Kees Brinkman, Suzanne Geerlings, et al.
Infectious Diseases and Therapy
|
July 6, 2017
A Survey of Patients' Perspectives on Outpatient HIV Care in the Netherlands
Esther A N Engelhard, Colette Smit, Frank P Kroon, et al.
Plos One
|
July 26, 2024
First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Piter Oosterhof, Ferdinand W N M Wit, Matthijs van Luin, et al.
AIDS Care
|
March 15, 2016
Structure and quality of outpatient care for people living with an HIV infection
Esther A N Engelhard, Colette Smit, Pythia T Nieuwkerk, et al.
Chronic Respiratory Disease
|
November 11, 2022
Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months
Marlise P de Roos, Sebastiaan Siegerink, Nynke G Dijkstra, et al.
AIDS (London, England)
|
May 18, 2023
COVID-19 in people with HIV in the Netherlands
Ferdinand W N M Wit, Peter Reiss, Bart Rijnders, et al.
AIDS (London, England)
|
August 2, 2008
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy
Radjin Steingrover, Katalyn Pogány, Evian Fernandez Garcia, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 99) with videos related to
Sort By:
Page
of 10
BMC Infectious Diseases
|
March 1, 2017
The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment
Ivo K Joore, Suzanne E Geerlings, Kees Brinkman, et al.
Chronic Respiratory Disease
|
February 9, 2024
Two-year diffusion capacity trajectory in COVID-19 pneumonia survivors
Marlise P de Roos, Rick M Heijnen, Nynke G Dijkstra, et al.
International Journal of Clinical Pharmacy
|
March 7, 2020
Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Femke Besemer, Cornelis Kramers, Kees Brinkman, et al.
The Lancet. Infectious Diseases
|
June 14, 2015
Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Mikaela Smit, Kees Brinkman, Suzanne Geerlings, et al.
Infectious Diseases and Therapy
|
July 6, 2017
A Survey of Patients' Perspectives on Outpatient HIV Care in the Netherlands
Esther A N Engelhard, Colette Smit, Frank P Kroon, et al.
Plos One
|
July 26, 2024
First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Piter Oosterhof, Ferdinand W N M Wit, Matthijs van Luin, et al.
AIDS Care
|
March 15, 2016
Structure and quality of outpatient care for people living with an HIV infection
Esther A N Engelhard, Colette Smit, Pythia T Nieuwkerk, et al.
Chronic Respiratory Disease
|
November 11, 2022
Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months
Marlise P de Roos, Sebastiaan Siegerink, Nynke G Dijkstra, et al.
AIDS (London, England)
|
May 18, 2023
COVID-19 in people with HIV in the Netherlands
Ferdinand W N M Wit, Peter Reiss, Bart Rijnders, et al.
AIDS (London, England)
|
August 2, 2008
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy
Radjin Steingrover, Katalyn Pogány, Evian Fernandez Garcia, et al.
Page
of 10